Cosmeca Korea has acquired a factory in Cheongju, South Korea, for 64 billion won (10.13% of total assets) to expand its OGM production capacity and meet rising global demand for K-beauty manufacturing. The investment signals growing importance of stable supply chains for indie brands and overseas buyers seeking reliable manufacturing partners.
Strategic investment in production base
The acquisition of land and buildings in Heungdeok-gu, Cheongju, Chungcheongbuk-do, announced on June 5, is a strategic move to expand production capacity (CAPA) and respond to the global surge in K-beauty demand. Cosmeca Korea's role as an OGM partner—handling product development, production, quality control, and delivery—has become critical as K-beauty popularity spreads worldwide.
Market signal: indie brands drive demand
Indie brands, experiencing remarkable global growth, prioritize rapid product launches and secure supply chains as key competitive advantages. Cosmeca Korea's expanded production base will enable faster and more reliable order fulfillment for both domestic and overseas clients, potentially attracting new brands and strengthening existing partnerships.
Financial performance supports expansion
Cosmeca Korea reported record-high consolidated revenue of 640.9 billion won and operating profit of 83.4 billion won last year. In Q1 of this year, its Korean entity achieved revenue of 142.2 billion won and operating profit of 17.8 billion won, up 91.3% and 120.8% year-over-year, respectively. These results underscore the need for expanded capacity.
Production capacity and category expansion
Current annual production capacity is about 1.3 billion units. The new factory will enable Cosmeca Korea to add hydrogel masks, sun care, and premium hair & body care products to its existing skincare-focused manufacturing capabilities, accelerating category expansion.
What buyers should watch
For overseas importers, distributors, and clinic buyers, this investment signals Cosmeca Korea's commitment to scaling production and diversifying product categories. The expanded capacity may lead to shorter lead times and greater flexibility for custom formulations, particularly for indie brands and medical aesthetics companies seeking reliable OGM partners.
A Cosmeca Korea representative stated: "As the global growth of K-beauty brands continues, the core of cosmetics manufacturing competitiveness is being distilled into a stable production base and rapid supply response. Through this investment, we will respond more systematically to the expanding global customer demand and further strengthen our foundation for mid- to long-term growth."
Source: Read the original report | Published: June 05, 2026